Telephone-administered versus live group cognitive behavioral stress management for adults with CFS.
Hall, Daniel L, Lattie, Emily G, Milrad, Sara F et al. · Journal of psychosomatic research · 2017 · DOI
Quick Summary
This study tested whether teaching stress management skills over the telephone worked as well as learning them in a live group setting for people with ME/CFS. Both formats helped reduce stress, but only the in-person group also improved physical symptoms like post-exertional malaise, chills, fever, and sleep quality. This suggests that meeting face-to-face may have extra benefits beyond just learning the techniques themselves.
Why It Matters
Many ME/CFS patients struggle to attend in-person appointments due to illness severity, making telehealth delivery attractive. However, this study suggests that live group interactions may provide therapeutic benefits beyond stress reduction alone—including direct improvements in core CFS symptoms—which could inform treatment accessibility and delivery decisions for this population.
Observed Findings
Both telephone and live CBSM significantly reduced perceived stress, with live format producing larger effect sizes (ε²=0.16 vs 0.095).
Only live CBSM showed significant improvements in CFS symptom frequency and severity scores (large effect sizes: ε²=0.19-0.23).
Live CBSM specifically improved post-exertional malaise, chills, fever, and restful sleep.
Telephone CBSM showed no significant changes in CFS symptom measures over time despite stress reduction.
Attendance rates were similar between both conditions, suggesting comparable engagement.
Inferred Conclusions
Live group-based CBSM may offer additional therapeutic mechanisms beyond stress reduction that benefit physical CFS symptoms.
The in-person group format appears necessary for achieving symptom-level improvements in this population.
Telehealth delivery is a viable option for stress reduction accessibility but may not fully replicate the benefits of live group interaction.
Future technology-enhanced interventions should explore how to preserve therapeutic group elements in remote delivery formats.
Remaining Questions
What specific aspects of live group interaction (social support, group cohesion, non-verbal communication, etc.) drive the superior symptom outcomes?
What This Study Does Not Prove
This study does not establish that the differences between live and telephone formats are solely due to in-person contact; unmeasured factors (group cohesion dynamics, social support activation, non-verbal communication) may explain the divergent outcomes. The study also cannot prove that symptom improvements are causally driven by stress reduction rather than other mechanisms, and generalizability may be limited by the predominantly female sample (90%) and participants willing to engage in group intervention.
Would hybrid or enhanced telehealth formats (video-based groups, increased facilitator contact) narrow the gap between delivery modalities?
How do individual patient characteristics predict responsiveness to each delivery format, and could matching patients to appropriate modalities improve outcomes?
Do symptom improvements from live CBSM persist over longer follow-up periods, and is repeated intervention necessary to maintain gains?